Rituximab/Related Articles: Difference between revisions
Jump to navigation
Jump to search
imported>Daniel Mietchen m (Robot: Starting Related Articles subpage. Please check and brush. For context, see here.) |
imported>Daniel Mietchen m (Robot: encapsulating subpages template in noinclude tag) |
||
| Line 1: | Line 1: | ||
{{subpages}} | <noinclude>{{subpages}}</noinclude> | ||
==Parent topics== | ==Parent topics== | ||
Revision as of 20:33, 11 September 2009
- See also changes related to Rituximab, or pages that link to Rituximab or to this page or whose text contains "Rituximab".
Parent topics
Subtopics
Bot-suggested topics
Auto-populated based on Special:WhatLinksHere/Rituximab. Needs checking by a human.
- Antineoplastic agent [r]: Drug that prevents the development, maturation, or spread of neoplastic cells. [e]
- B-Cell chronic lymphocytic leukemia [r]: Chronic leukaemia characterized by abnormal B-lymphocytes and often generalized lymphadenopathy. [e]
- Bronchiolitis obliterans organizing pneumonia [r]: Disease formerly considered a form of interstitial pneumonia, but may be associated with toxic fumes, infection, and connective tissue disease. [e]
- Food and Drug Administration [r]: The agency of the United States Department of Health and Human Services responsible for regulating food, dietary supplements, drugs, biological medical products, blood products, medical devices, radiation-emitting devices, veterinary products, and cosmetics. [e]
- Lymphoma [r]: A malignancy of the lymphoid immune cells. [e]
- Rheumatoid arthritis [r]: A chronic, inflammatory autoimmune disorder that causes the immune system to attack the joints. [e]